Cite
MLA Citation
G. Tan et al.. “102P A multicenter retrospective cohort study comparing the efficacy and safety of lenvatinib in combination with PD-1 inhibitor with or without transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.” Immuno-oncology technology, vol. 16, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100172207143.0x00000c